Pharmagen Stock Price History
Below is the normalized historical share price chart for Pharmagen extending back to March 09, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions.
If you're considering investing in Pharmagen Stock, it is important to understand the factors that can impact its price. Pharmagen maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Pharmagen exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement.
Preferred Stock Total Equity is likely to rise to about 34.6 K in 2025, despite the fact that Total Stockholder Equity is likely to grow to (6.6 M). . Price To Sales Ratio is likely to drop to 0.25 in 2025. Price Earnings Ratio is likely to drop to -0.22 in 2025. Pharmagen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | Beta 0.028 |
Pharmagen |
Sharpe Ratio = -0.1302
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PHRX |
Estimated Market Risk
13.02 actual daily | 96 96% of assets are less volatile |
Expected Return
-1.69 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pharmagen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmagen by adding Pharmagen to a well-diversified portfolio.
Pharmagen Stock Price History Chart
There are several ways to analyze Pharmagen Stock price data. The simplest method is using a basic Pharmagen candlestick price chart, which shows Pharmagen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 13, 2024 | 1.0E-4 |
Lowest Price | January 28, 2025 | 0.0 |
Pharmagen Stock Price History Data
The price series of Pharmagen for the period between Tue, Dec 17, 2024 and Mon, Mar 17, 2025 has a statistical range of 0.0 with a coefficient of variation of 100.77. The price distribution for the period has arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed stock split (45:1) on 7th of December 2011.Open | High | Low | Close | Volume | ||
03/14/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/13/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/12/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/11/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/10/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/07/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/06/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/05/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/04/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
03/03/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/28/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/27/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/26/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/25/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/24/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/21/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/20/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/19/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/18/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/14/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/13/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/12/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/11/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/10/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/07/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/06/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/05/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/04/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
02/03/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
01/31/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
01/30/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
01/29/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
01/28/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 129,976 | |
01/27/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/24/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/23/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/22/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/21/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/17/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/16/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/15/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/08/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/03/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/02/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/31/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/30/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/27/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/26/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/24/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/23/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/20/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/19/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/17/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/16/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/13/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
About Pharmagen Stock history
Pharmagen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pharmagen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pharmagen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pharmagen stock prices may prove useful in developing a viable investing in Pharmagen
Last Reported | Projected for Next Year | ||
Net Loss | -5.8 M | -5.5 M |
Pharmagen Stock Technical Analysis
Pharmagen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.